Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

0.3775
-0.0235-5.86%
Volume:167.06K
Turnover:62.98K
Market Cap:14.26M
PE:-0.86
High:0.3850
Open:0.3800
Low:0.3601
Close:0.4010
52wk High:1.33
52wk Low:0.2500
Shares:37.77M
Float Shares:25.85M
Volume Ratio:1.46
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4366
EPS(LYR):-0.4366
ROE:-2174.98%
ROA:-247.30%
PB:-9.14
PE(LYR):-0.86

Loading ...

NeuroSense Therapeutics to Present at H.C. Wainwright Global Investment Conference

Reuters
·
1 hour ago

Neurosense Therapeutics Ltd: to Effect Reverse Share Split of Co’s Ordinary Shares at Ratio of 1-for-20

THOMSON REUTERS
·
17 hours ago

NeuroSense Therapeutics Effects 1-for-20 Reverse Stock Split on Sept. 14, 2026

Reuters
·
17 hours ago

NeuroSense Therapeutics Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Sep 03

Neurosense Therapeutics Ltd. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $8

THOMSON REUTERS
·
Sep 03

NeuroSense announces redesigned development plan for PrimeC

TIPRANKS
·
Aug 31

NeuroSense Targets Faster, Lower-Cost ALS Approval Path for PrimeC Under Revamped Development Plan

Reuters
·
Aug 31

NeuroSense Plans Head-to-Head PrimeC Trial Versus Mitsubishi Tanabe’s Edaravone in ALS

Reuters
·
Aug 31

Neurosense Unveils Accelerated, Capital-Efficient Strategy to Advance Primec Toward Potential Approval in ALS

THOMSON REUTERS
·
Aug 31

NeuroSense Therapeutics Shareholders Authorized Board to Pursue Reverse Stock Split Range 1-for-4 to 1-for-40

Reuters
·
Aug 28

NeuroSense Announces Shareholder Letter Availability

Reuters
·
Aug 13

NeuroSense Targets December 2026 Canada Filing for PrimeC ALS Drug Amid Phase 3 Paragon Preparations

Reuters
·
Aug 13

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)

TIPRANKS
·
Aug 11

NeuroSense sees December 2026 as filing date for NDS for PrimeC

TIPRANKS
·
Aug 06

NeuroSense Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 01

NeuroSense Amends JonesTrading Equity Distribution Agreement for up to $3.79 Million Share Sales

Reuters
·
Aug 01

Neurosense Therapeutics Ltd Expected to Post Breakeven Results a Share - Earnings Preview

Reuters
·
Jul 28

Neurosense Therapeutics - Expects to File Submission to Health Canada in Coming Months

THOMSON REUTERS
·
Jul 22

Neurosense Therapeutics Announces Press Release Availability

Reuters
·
Jul 22

Neurosense Plans Primec New Drug Filing with Health Canada for ALS

Reuters
·
Jul 22